Y-mAbs Therapeutics, Inc. (YMAB)
NASDAQ: YMAB · IEX Real-Time Price · USD
12.53
+0.20 (1.62%)
Jul 26, 2024, 4:00 PM EDT - Market closed
Y-mAbs Therapeutics Market Cap
Y-mAbs Therapeutics has a market cap or net worth of $549.85 million as of July 26, 2024. Its market cap has increased by 76.06% in one year.
Market Cap
549.85M
Enterprise Value
475.28M
1-Year Change
76.06%
Ranking
Category
Stock Price
$12.53
Market Cap Chart
Since September 21, 2018, Y-mAbs Therapeutics's market cap has decreased from $783.00M to $549.85M, a decrease of -29.78%. That is a compound annual growth rate of -5.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 541.10M | 81.88% |
| Dec 29, 2023 | 297.50M | 39.61% |
| Dec 30, 2022 | 213.10M | -69.88% |
| Dec 31, 2021 | 707.50M | -64.73% |
| Dec 31, 2020 | 2.01B | 61.56% |
| Dec 31, 2019 | 1.24B | 78.50% |
| Dec 31, 2018 | 695.50M | -11.17% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OmniAb | 552.25M |
| Jin Medical International | 551.83M |
| Anavex Life Sciences | 550.17M |
| Fulcrum Therapeutics | 550.06M |
| Terns Pharmaceuticals | 549.11M |
| Cross Country Healthcare | 544.91M |
| PureTech Health | 538.47M |
| Pacific Biosciences of California | 505.22M |